Serum BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand) levels in the first trimester may predict the future development of gestational diabetes mellitus
Diabetes & Metabolic Syndrome: Clinical Research & Reviews · 2024
DOI: 10.1016/j.dsx.2024.103019 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2024. Verfasst von Sudipta Banerjeee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology & Metabolism, IPGME&R and SSKM Hospital, Kolkata, West Bengal, India. Hauptthemen laut MEDLINE: B-Cell Activating Factor, Diabetes, Gestational, Tumor Necrosis Factor Ligand Superfamily Member 13, Pregnancy Trimester, First. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Government of West Bengal Department of Science and Technology and Biotechnology, Department of Science and Technology, Government of West Bengal.
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND: Gestational diabetes mellitus (GDM) is a prevalent condition with an unclear pathogenesis. B-cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL) are potential key players in GDM. PARTICIPANTS, MATERIALS, AND METHODS: In a longitudinal observational study, we monitored women from the first trimester through 24-28 weeks of gestation, focusing on the development of GDM. Serum levels of BAFF and APRIL, as well as their mRNA expression, were evaluated in both the first and third trimesters. Furthermore, we assessed cytokines, adipokines, and placental hormones in the serum. RESULTS: In the first trimester, participants who later developed GDM exhibited elevated serum BAFF and reduced serum APRIL levels, although the mRNA expression of these molecules was similar to controls. Serum BAFF exhibited significant positive correlations with metabolic markers and placental hormones. Conversely, serum APRIL was negatively correlated with insulin resistance and inflammatory markers but positively correlated with adiponectin. In the early third trimester, GDM participants continued to display higher serum BAFF levels and lower serum APRIL levels than controls. There was no significant difference in mRNA expression of BAFF between GDM and control groups. Conversely, APRIL mRNA expression was significantly lower in the GDM group. The predictive potential of first-trimester BAFF and APRIL levels for future GDM development was explored, with both molecules demonstrating strong predictive capability. DISCUSSION AND CONCLUSION: This study suggests that elevated serum BAFF and reduced serum APRIL levels during pregnancy may be associated with the development of GDM. These biomarkers can serve as potential early predictors for GDM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology & Metabolism, IPGME&R and SSKM Hospital, Kolkata, West Bengal, India.
- Department of Endocrinology & Metabolism, IPGME&R and SSKM Hospital, Kolkata, West Bengal, India. Electronic address: dr.r.bhatta@gmail.com.
Förderung
- Government of West Bengal Department of Science and Technology and Biotechnology
- Department of Science and Technology, Government of West Bengal
Zitieren
APA
Banerjeee, S., Adhikary, P., Dey, B. K., Chowdhury, S., & Bhattacharjee, R. (2024). Serum BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand) levels in the first trimester may predict the future development of gestational diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. https://doi.org/10.1016/j.dsx.2024.103019
Vancouver
Banerjeee S, Adhikary P, Dey BK, Chowdhury S, Bhattacharjee R. Serum BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand) levels in the first trimester may predict the future development of gestational diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2024. doi:10.1016/j.dsx.2024.103019
BibTeX
@article{Banerjeee2024,
author = {Banerjeee, Sudipta and Adhikary, Pieu and Dey, Bishal Kumar and Chowdhury, Subhankar and Bhattacharjee, Rana},
title = {Serum BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand) levels in the first trimester may predict the future development of gestational diabetes mellitus},
journal = {Diabetes & Metabolic Syndrome: Clinical Research & Reviews},
year = {2024},
doi = {10.1016/j.dsx.2024.103019}
}
EUVIMED